Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS)

Pediatric Dermatology

Volumn 26, Issue 5, 2009, Pages 536-546

  Newell, Brandon D ^a   Moinfar, Maryam ^b   Mancini, Anthony J ^b   Nopper, Amy Jo ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CORTICOSTEROID; ETIRACETAM; FELBAMATE; GABAPENTIN; IMMUNOGLOBULIN; LAMOTRIGINE; LITHIUM; METHYLPREDNISOLONE SODIUM SUCCINATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRAMOCAINE; PREDNISOLONE; PREDNISONE; PRIMIDONE; STEROID; VALPROIC ACID; WHITE PETROLATUM;

ANTICONVULSANT THERAPY; ARTICLE; BEHAVIOR DISORDER; BIPOLAR DISORDER; BRAIN ABSCESS; BRAIN CYST; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL FEATURE; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; FEBRILE CONVULSION; FEMALE; FEVER; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LIVER DISEASE; LUNG DISEASE; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; MIGRAINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EPILEPSY; FEMALE; FEVER; HUMANS; INFANT; LYMPHATIC DISEASES; MALE; RETROSPECTIVE STUDIES; SKIN; TREATMENT OUTCOME;

EID: 70350014908     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00870.x     Document Type: Article

References (48)

1. Sheretz EF, Jegasothy BV, Lazarus GS. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid pulse therapy. J Am Acad Dermol 1985 12 (1 Pt 2 178 181.
2. Brown M, Schubert T. Phenytoin hypersensitivity hepatitis and mononucleosis syndrome. J Clin Gastroenterol 1986 8 : 469 477.
3. Baruzzi A, Contin M, Barbara G et al. Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone. Clin Neuropharmacol 2003 26 : 177 178.
4. Black DM, Fivenson DP. Case report of antiepileptic drug hypersensitivity reaction: pseudolymphoma syndrome. Fam Pract Res J 1989 8 : 107 111.
5. Choi TS, Doh KS, Kim SH et al. Clinicopathological and genotypic aspects of antivonvulsant-induced pseudolymhoma syndrome. Br J Dermatol 2003 148 : 730 736.
6. Lachgar T, Touil Y. The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital. Allergy Immunol 2001 33 : 173 175.
7. Ivry S, Shteinmintz D, Tabenkin H. Carbamazepine hypersensitivity symptoms. Harefuah 2000 138 : 545 547.
8. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Int Med 1995 155 : 2285 2290.
9. De Vriese AS, Philippe J, Van Renterghem DM et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and a review of the literature. Medicine 1995 74 : 144 151.
10. Spielberg SP, Gordon GB, Blake DE et al. Anticonvulsant toxicity in vitro: possible role of arene oxides. J Pharmcol Exper Therapy 1981 217 : 386 389.
11. Carroll MC, Yueng-Yue KA, Esterly NB et al. Drug induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001 108 : 485 492.
12. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatol 2003 206 : 353 356.
13. Brown TS, Appel JE, Kasteler JS et al. Hypersensitivity reaction in a child due to lamotrigine. Pediatr Dermatol 1999 16 : 46 49.
14. Mylonnakis E, Vittorio CC, Hollik DA et al. Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome. Ann Pharmacother 1999 33 : 557 559.
15. Sarris BM, Wong JG. Multisystem hypersensitivity reaction to lamotrigine. Neurol 1999 53 : 1367.
16. Nashed MH, Liao L. Possible atypical cross-sensitivity between phenytoin and carbamazepine in the anticonvulsant hypersensitivity syndrome. Pharmacotherapy 2001 21 : 502 505.
17. Conger LA Jr., Grabski WJ. Dilantin hypersensitivity reaction. Cutis 1996 57 : 223 226.
18. Bertz RJ, Howrie DL. Diazepam by continuous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann Pharmacotherapy 1993 27 : 298 301.
19. Descamps V, Bouscarat F, Laglenne S et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997 137 : 605 608.
20. Fujino Y, Nakajima M, Inoue H et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002 51 : 771 774.
21. Scheuerman O, Nofech-Moses Y, Rachmel A et al. Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin. Pediatrics 2001 107 : E14.
22. Gennis MA, Vemuri R, Burns EA et al. Familial occurance of hypersensitivity to phenytoin. Am J Med 1991 91 : 631 634.
23. Chan HL, Stern RS, Arndt KA et al. The incidence of erythema multiforme, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 2000 126 : 43 71.
24. Rzany B, Correia O, Kelly JP et al. Risk of Stevens-Johnson syndrome and toxic epidermolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 1999 353 : 1033 1034.
25. Troger U, Brandt W, Rose W. Development of a pulmonary phenytoin-associated hypersensitivity reaction despite concomitant dexamethasone and prednisolone administration. Int J Clin Pharmacol Ther 2000 38 : 452 456.
26. Kahn HD, Faguet GB, Agee JF et al. Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital. Arch Intern Med 1984 144 : 1677 1679.
27. Roberts EA, Spielberg SP, Goldbach M et al. Phenobarbital hepatotoxicity in an 8-month-old infant. J Hepatol 1990 10 : 235 239.
28. Mockli G, Crowley M, Stern R et al. Massive hepatic necrosis in a child after administration of phenobarbital. Am J Gastroenterol 1989 84 : 820 822.
29. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic syndrome in children. Ann Pharmacother 2001 35 : 533 538.
30. Harney J, Glasberg MR. Myopathy and hypersensitivity to phenytoin. Neurol 1983 33 : 790 791.
31. Engel JN, Mellul VG, Goodman DB. Phenytoin hypersensitivity: a case of severe rhabdomyolysis. Am J Med 1986 81 : 928 930.
32. Gupta A, Eggo MC, Uetrecht JP et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to the anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992 51 : 56 67.
33. Kaur S, Sarkar R, Thami GP et al. Anticonvulsant hypersensitivity syndrome. Pediatr Dermatol 2002 19 : 142 145.
34. Moss DM, Rudis M, Henderson SO. Cross-sensitivity and the anticonvulsant hypersensitivity syndrome. J Emer Med 1999 17 : 503 506.
35. Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991 127 : 1361 1364.
36. Hamer HM, Morriss HH. Successful treatment with gabapentin in the presence of hypersensitivity syndrome to phenytoin and carbamazepine: a report of three cases. Seizure 1999 8 : 190 192.
37. Chopra S, Levell NJ, Cowley G et al. Systemic steroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996 134 : 1109 1112.
38. Howard PA, Engen PL, Dunn MI. Phenytoin hypersensitivity syndrome. DICP 1991 25 : 929 932.
39. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Investig 1988 82 : 1826 1832.
40. Bessmertny O, Pham T. Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Curr Aller Asthma Rep 2002 2 : 34 39.
41. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998 282 : 490 493.
42. Chapman MS, Zug KA, Lewis LD. Lamotrigine and phenobarbitone-associated hypersensitivity syndrome: resolution without corticosteroids. Br J Dermatol 1998 138 : 710 711.
43. Harman KE, Morris SD, Higgins EM. Persistent anticonvulsant hypersensitivity syndrome responding to cyclosporin. Clin Exper Dermatol 2003 28 : 364 365.
44. Heng MC, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1991 15 (5 Pt 1 778 786.
45. Frangomiannis NG, Boridy I, Mazhar M et al. Cyclophosphamide in the treatment of toxic epidermal necrolysis. Southern Med 1996 89 : 1001 1003.
46. Tomsick RS. The phenytoin syndrome. Cutis 1983 32 : 535 541.
47. Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 2003 112 (6 Pt 1 1430 1436.
48. Cumbo-Nacheli G, Weinberger J, Alkhalil M et al. Anticonvulsant hypersensitivity syndrome: is there a role for immunomodulation? Epilepsia 2008 49 : 2108 2112.